RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL

AVITA Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$13.14+0.10 (+0.77%)

Close on Oct 19, 2026

Market cap: $404.05M
P/E (TTM): –
Dividend yield: –

AVITA Medical, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30
Depreciation & Amortization	2.35	1.13	0.63	0.72	0.47	0.27	0.11
Stock-Based Compensation	9.52	13	8.38	5.66	16	1.95	1.42
Change in Inventory	-0.47	-2.16	-3.69	-0.75	-0.47	0.02	-0.09
Change in Accounts Payable	2.75	0.34	0.81	-1.33	2.31	0.07	0.28
Change in Unearned Revenue	-0.03	-0.03	-0.34	0.64	0.01	0.43	–
Operating Cash Flow	-31	-49	-38	-26	-23	-19	-13
Capital Expenditures	-1.01	-9.17	-1.38	-0.89	-0.59	-1.02	-0.37
Purchase of Investments	-13	-25	-79	–	–	–	–
Sale & Maturity of Investments	28	71	79	–	–	–	–
Investing Cash Flow	12	37	1.61	-1.17	-0.85	-1.23	-0.37
Stock Issued	15	–	–	69	82	32	23
Debt Issued	–	–	39	–	–	–	–
Financing Cash Flow	15	3.51	40	64	77	30	21
Foreign Exchange Rate Adjustments	–	–	-0.02	0.13	0.00	0.16	0.10
Net Change in Cash	-3.81	-8.07	3.95	37	53	9.39	8.07
Free Cash Flow	-32	-58	-39	-27	-23	-20	-13
Income Taxes Paid	0.02	0.04	0.04	0.04	–	–	–
Interest Paid	4.98	5.36	1.14	0.00	0.04	0.03	0.02

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 81.6%
Operating margin: -46.6%
Net margin: -57.0%
Return on equity, FY2025: 799.7%

Financial strength

Current ratio: 0.41
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 13.3%

Valuation

P/E ratio: –
Price to sales: 5.34
Price to book: –
Dividend yield: –